Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Coiante Insider Profile
11 Followers
Scott Coiante, CFO at Agile Therapeutics, holds 0.00 shares in Agile Therapeutics (Ticker: AGRX), holds 145.06K shares in Aprea Therapeutics (Ticker: APRE).
Scott Coiante Agile Therapeutics (AGRX)CFO
Agile Therapeutics (AGRX)
CFO
Not Ranked
Scott Coiante has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
SVP & CFO
Roles that Scott Coiante holds in companies
Most Profitable Insider Trade
The most profitable trade made by Scott Coiante
Scott Coiante's Trading History
Agile Therapeutics
Aug 26, 2024
―
Uninformative Sell
22.80K
$0.00
Aprea Therapeutics
Aug 01, 2022
SVP & CFO
Uninformative Buy
―
$442.45K
List of latest transactions for each holding click on a transaction to see Scott Coiante's performance on stock
You May Also Like
Scott Coiante insider profile FAQ
What is the percentage of profitable transactions made by Scott Coiante?
The percentage of profitable transactions made by Scott Coiante is ―.
What is the average return per transaction made by Scott Coiante?
The average return per transaction made by Scott Coiante is ―.
What stocks does Scott Coiante hold?
Scott Coiante holds: AGRX, APRE stocks.
What was Scott Coiante’s latest transaction?
Scott Coiante latest transaction was an Uninformative Sell of $22.80K.
What was Scott Coiante's most profitable transaction?
Scott Coiante’s most profitable transaction was an Informative Buy of APRE stock on October 7, 2019. The return on the trade was 45.10%.
What is Scott Coiante's role in Agile Therapeutics?
Scott Coiante's role in Agile Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.